Bone marrow transplant is the process of replacing damaged or destroyed bone marrow in a patient with healthy bone marrow cells. This transplant method can be life-saving, especially in the treatment of serious diseases such as acute leukemias and lymphomas that are resistant to standard chemotherapy.
Stem cells can be collected from the patient's own body or from another person, i.e., a donor.
If the patient has no related donor, a donor is sought in national and international (DKMS and BMDW) databases. HLA typing test is used to check compatibility, and a preliminary search is conducted. If a compatible donor is found, blood samples are taken to confirm HLA typing and other screening tests are performed. This process can take up to three months. Once a sufficient number of stem cells are collected from the donor, the transplant procedure is sent to the centers in collaboration with Well Dems Travel Agency.
Haploidentical stem cell transplantation is a specialized transplant method applied in a limited number of centers worldwide. In this method, a 10/10 tissue match is not required, and the patient's half-matched relatives can be donors. It is considered the transplant method of the future.
Bone marrow transplant is used for hematological diseases such as leukemia, myelodysplastic syndrome, lymphoma, multiple myeloma, and aplastic anemia. It is also used for cancer types that do not respond to chemotherapy and congenital disorders.
After the transplant, the patient's general condition improves as blood cell levels rise, and they reach a state where they can be discharged. Follow-up visits continue for three months to a year, depending on the patient's progress. Patients are advised to protect their immune systems, avoid crowded places, and maintain a careful diet. Most patients can return to work within 3-6 months if they adhere to the precautions.
Chemotherapy can sometimes affect fertility. For those planning to have children, in vitro fertilization methods can be used, and freezing sperm or eggs before treatment may be an option.
Before an allogeneic transplant, both the patient and the donor undergo comprehensive testing. If a compatible donor is found, stem cell mobilization is initiated, and after collecting sufficient cells, the transplant is performed. After the transplant, the patient stays in the hospital for about a month to stabilize blood counts and ensure adequate nutrition. Once clinically stable, they are discharged and regularly monitored through follow-up visits.
Well Dems Travel Agency provides services in a sterile environment that meets international standards. Interdisciplinary collaboration is emphasized, and support is provided from all relevant branches when necessary. The transplanted stem cells are prepared in licensed GMP laboratories, and all cells are analyzed for viability, count, and activity.
Well Dems Travel Agency performs haploidentic transplants through alpha/beta T cell depletion to reduce the deadly complications of graft-versus-host disease. Additionally, it provides virus-specific T cells to combat resistant viral infections. By utilizing the latest transplant technologies, we offer our patients the best chance of a healthy life and provide competitive prices with affordable transplant packages.
CAR T-cell therapy is a type of immunotherapy that enhances the immune system's ability to fight cancer by genetically modifying T cells. Well Dems Travel Agency is one of the pioneering institutions in Turkey and the region offering this new treatment.
In CAR T-cell therapy, the patient's T cells are genetically engineered in a laboratory to produce chimeric antigen receptors (CARs) that are specific to cancer cells. The modified T cells can then recognize and destroy the cancer cells.
CAR T-cell therapy is used in the treatment of resistant B-cell Acute Lymphoblastic Leukemia (B-ALL), B-cell Lymphoma, and Multiple Myeloma. Well Dems Travel Agency has successfully implemented CAR T therapy, particularly for these types of cancers.
For patients or donors found suitable for CAR T-cell therapy, peripheral blood cells are collected. These cells are genetically engineered and multiplied in a laboratory, and quality assurance tests are completed. Before the treatment, patients undergo chemotherapy for lymphodepletion. The modified CAR T cells are then administered to the patient intravenously.
The treatment process takes about two weeks. Side effects are managed by our doctors, and the discharge time for the patient is generally less than a month. After treatment, IVIG (immunoglobulin) therapy is required for up to a year, and regular follow-up is conducted.
International studies report overall response rates of over 90% in Acute Lymphoblastic Leukemia patients and over 80% in Non-Hodgkin Lymphoma patients. At Well Dems Travel Agency, we offer these success rates to our patients.
With Well Dems Travel Agency, you can have a safe journey through bone marrow transplant and CAR T-cell therapy processes, supported by our experienced teams, advanced technology, and superior patient care.